ijms-logo

Journal Browser

Journal Browser

The Role and Characterization of Neutrophils in Human Diseases

A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Pathology, Diagnostics, and Therapeutics".

Deadline for manuscript submissions: closed (15 October 2023) | Viewed by 16591

Special Issue Editors


E-Mail Website
Guest Editor
Department of Surgery, Beth Israel Deaconess Medical Center Department of Surgery, ST-8M10A 330 Brookline Ave, Boston, MA 02215, USA
Interests: trauma; neutrophils; innate immunology; mitochondrial DAMPs; nosocomial pneumonia

E-Mail Website
Guest Editor
Department of Genetics, Cell and Immunobiology, Semmelweis University, 999024 Budapest, Hungary
Interests: cell biology; cell physiology; phylogeny of signalling; chemotaxis/migration; cell adhesion; drug-targeting; anti-tumor substances; chemotactic drug-targeting; impedimetry

Special Issue Information

Dear Colleagues,

Neutrophils are the most abundant leukocytes in circulation, and have been regarded as the first line of defense in the innate arm of the immune system. They capture and destroy invading microorganisms through phagocytosis and intracellular degradation, the release of granules, and the formation of neutrophil extracellular traps after detecting pathogens. Neutrophils also participate as mediators of inflammation. The classical view of these leukocytes is that neutrophils constitute a homogenous population of terminally differentiated cells with a unique function. However, evidence accumulated in recent years has revealed that neutrophils present a large phenotypic heterogeneity and functional versatility, which place neutrophils as important modulators of both inflammation and immune responses. Indeed, the roles played by neutrophils in homeostatic conditions as well as in pathological inflammation and immune processes are the focus of a renovated interest in neutrophil biology.

This Special Issue attempts to explore the recent advances in neutrophils related to human diseases. 

The Special Issue aims (i) to present the neutrophil-specific assays that have gained ground in the recent years and (ii) to discuss the relevance of each neutrophil-specific technique. This approach to the issue also provides a way to discuss neutrophil-dedicated methods in cell physiology, immunology and genetics.

The issues raised in papers should be supported by sufficient data or evidence.

Dr. Kiyoshi Itagaki
Dr. Kőhidai László 
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Published Papers (9 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Research

Jump to: Review, Other

15 pages, 3047 KiB  
Article
The GAG-Binding Peptide MIG30 Protects against Liver Ischemia-Reperfusion in Mice
by Thiago Henrique Caldeira Oliveira, Vincent Vanheule, Sofie Vandendriessche, Fariba Poosti, Mauro Martins Teixeira, Paul Proost, Mieke Gouwy and Pedro Elias Marques
Int. J. Mol. Sci. 2022, 23(17), 9715; https://doi.org/10.3390/ijms23179715 - 26 Aug 2022
Cited by 1 | Viewed by 1577
Abstract
Ischemia-reperfusion injury (IRI) drives graft rejection and is the main cause of mortality after liver transplantation. During IRI, an intense inflammatory response marked by chemokine production and neutrophil recruitment occurs. However, few strategies are available to restrain this excessive response. Here, we aimed [...] Read more.
Ischemia-reperfusion injury (IRI) drives graft rejection and is the main cause of mortality after liver transplantation. During IRI, an intense inflammatory response marked by chemokine production and neutrophil recruitment occurs. However, few strategies are available to restrain this excessive response. Here, we aimed to interfere with chemokine function during IRI in order to disrupt neutrophil recruitment to the injured liver. For this, we utilized a potent glycosaminoglycan (GAG)-binding peptide containing the 30 C-terminal amino acids of CXCL9 (MIG30) that is able to inhibit the binding of chemokines to GAGs in vitro. We observed that mice subjected to IRI and treated with MIG30 presented significantly lower liver injury and dysfunction as compared to vehicle-treated mice. Moreover, the levels of chemokines CXCL1, CXCL2 and CXCL6 and of proinflammatory cytokines TNF-α and IL-6 were significantly reduced in MIG30-treated mice. These events were associated with a marked inhibition of neutrophil recruitment to the liver during IRI. Lastly, we observed that MIG30 is unable to affect leukocytes directly nor to alter the stimulation by either CXCL8 or lipopolysaccharide (LPS), suggesting that its protective properties derive from its ability to inhibit chemokine activity in vivo. We conclude that MIG30 holds promise as a strategy to treat liver IRI and inflammation. Full article
(This article belongs to the Special Issue The Role and Characterization of Neutrophils in Human Diseases)
Show Figures

Figure 1

Review

Jump to: Research, Other

17 pages, 1853 KiB  
Review
Neutrophils and Anesthetic Drugs: Implications in Onco-Anesthesia
by Alexandru Leonard Alexa, Sergiu Sargarovschi and Daniela Ionescu
Int. J. Mol. Sci. 2024, 25(7), 4033; https://doi.org/10.3390/ijms25074033 - 04 Apr 2024
Viewed by 503
Abstract
Apart from being a significant line of defense in the host defense system, neutrophils have many immunological functions. Although there are not many publications that accurately present the functions of neutrophils in relation to oncological pathology, their activity and implications have been studied [...] Read more.
Apart from being a significant line of defense in the host defense system, neutrophils have many immunological functions. Although there are not many publications that accurately present the functions of neutrophils in relation to oncological pathology, their activity and implications have been studied a lot recently. This review aims to extensively describe neutrophils functions’; their clinical implications, especially in tumor pathology; the value of clinical markers related to neutrophils; and the implications of neutrophils in onco-anesthesia. This review also aims to describe current evidence on the influence of anesthetic drugs on neutrophils’ functions and their potential influence on perioperative outcomes. Full article
(This article belongs to the Special Issue The Role and Characterization of Neutrophils in Human Diseases)
Show Figures

Figure 1

16 pages, 4343 KiB  
Review
The Role of Neutrophils in ANCA-Associated Vasculitis: The Pathogenic Role and Diagnostic Utility of Autoantibodies
by Agata Walulik, Kinga Łysak, Michał Błaszkiewicz, Ignacy Górecki and Krzysztof Gomułka
Int. J. Mol. Sci. 2023, 24(24), 17217; https://doi.org/10.3390/ijms242417217 - 07 Dec 2023
Viewed by 1018
Abstract
Recent years have brought progress in understanding the role of the neutrophil, dispelling the dogma of homogeneous cells mainly involved in the prime defence against pathogens, shedding light on their pathogenic role in inflammatory diseases and on the importance of antineutrophil-cytoplasmic antibodies’ pathogenic [...] Read more.
Recent years have brought progress in understanding the role of the neutrophil, dispelling the dogma of homogeneous cells mainly involved in the prime defence against pathogens, shedding light on their pathogenic role in inflammatory diseases and on the importance of antineutrophil-cytoplasmic antibodies’ pathogenic role in ANCA-associated vasculitides vasculitis (AAV). Myeloperoxidase (MPO) and proteinase 3 (PR3) expressed in neutrophil granulocytes are the most common targets for ANCAs and contribute to the formation of MPO-ANCAs and PR3-ANCAs which, released to the bloodstream, become an excellent diagnostic tool for AAV. In this study, we focus on increasing the clinical and experimental evidence that supports the pathogenic role of ANCAs in AAV. Additionally, we discuss the diagnostic utility of ANCAs for disease activity and prognosis in AAV. Understanding the central role of ANCAs in AAV is crucial for advancing our knowledge of these complex disorders and developing targeted therapeutic strategies in the era of personalized medicine. Full article
(This article belongs to the Special Issue The Role and Characterization of Neutrophils in Human Diseases)
Show Figures

Figure 1

21 pages, 1372 KiB  
Review
Role of Neutrophil Extracellular Traps in Health and Disease Pathophysiology: Recent Insights and Advances
by Md. Monirul Islam and Naoshi Takeyama
Int. J. Mol. Sci. 2023, 24(21), 15805; https://doi.org/10.3390/ijms242115805 - 31 Oct 2023
Cited by 4 | Viewed by 2140
Abstract
Neutrophils are the principal trouper of the innate immune system. Activated neutrophils undergo a noble cell death termed NETosis and release a mesh-like structure called neutrophil extracellular traps (NETs) as a part of their defensive strategy against microbial pathogen attack. This web-like architecture [...] Read more.
Neutrophils are the principal trouper of the innate immune system. Activated neutrophils undergo a noble cell death termed NETosis and release a mesh-like structure called neutrophil extracellular traps (NETs) as a part of their defensive strategy against microbial pathogen attack. This web-like architecture includes a DNA backbone embedded with antimicrobial proteins like myeloperoxidase (MPO), neutrophil elastase (NE), histones and deploys in the entrapment and clearance of encountered pathogens. Thus NETs play an inevitable beneficial role in the host’s protection. However, recent accumulated evidence shows that dysregulated and enhanced NET formation has various pathological aspects including the promotion of sepsis, pulmonary, cardiovascular, hepatic, nephrological, thrombotic, autoimmune, pregnancy, and cancer diseases, and the list is increasing gradually. In this review, we summarize the NET-mediated pathophysiology of different diseases and focus on some updated potential therapeutic approaches against NETs. Full article
(This article belongs to the Special Issue The Role and Characterization of Neutrophils in Human Diseases)
Show Figures

Figure 1

16 pages, 918 KiB  
Review
Neurotrophins: Expression of Brain–Lung Axis Development
by Sara Manti, Federica Xerra, Giulia Spoto, Ambra Butera, Eloisa Gitto, Gabriella Di Rosa and Antonio Gennaro Nicotera
Int. J. Mol. Sci. 2023, 24(8), 7089; https://doi.org/10.3390/ijms24087089 - 11 Apr 2023
Cited by 6 | Viewed by 2000
Abstract
Neurotrophins (NTs) are a group of soluble growth factors with analogous structures and functions, identified initially as critical mediators of neuronal survival during development. Recently, the relevance of NTs has been confirmed by emerging clinical data showing that impaired NTs levels and functions [...] Read more.
Neurotrophins (NTs) are a group of soluble growth factors with analogous structures and functions, identified initially as critical mediators of neuronal survival during development. Recently, the relevance of NTs has been confirmed by emerging clinical data showing that impaired NTs levels and functions are involved in the onset of neurological and pulmonary diseases. The alteration in NTs expression at the central and peripheral nervous system has been linked to neurodevelopmental disorders with an early onset and severe clinical manifestations, often named "synaptopathies" because of structural and functional synaptic plasticity abnormalities. NTs appear to be also involved in the physiology and pathophysiology of several airway diseases, neonatal lung diseases, allergic and inflammatory diseases, lung fibrosis, and even lung cancer. Moreover, they have also been detected in other peripheral tissues, including immune cells, epithelium, smooth muscle, fibroblasts, and vascular endothelium. This review aims to provide a comprehensive description of the NTs as important physiological and pathophysiological players in brain and lung development. Full article
(This article belongs to the Special Issue The Role and Characterization of Neutrophils in Human Diseases)
Show Figures

Figure 1

16 pages, 1592 KiB  
Review
Neutrophils in Health and Disease: From Receptor Sensing to Inflammasome Activation
by Agnieszka Iwaniuk and Ewa Jablonska
Int. J. Mol. Sci. 2023, 24(7), 6340; https://doi.org/10.3390/ijms24076340 - 28 Mar 2023
Cited by 2 | Viewed by 1621
Abstract
Neutrophils—polymorphonuclear cells (PMNs) are the cells of the initial immune response and make up the majority of leukocytes in the peripheral blood. After activation, these cells modify their functional status to meet the needs at the site of action or according to the [...] Read more.
Neutrophils—polymorphonuclear cells (PMNs) are the cells of the initial immune response and make up the majority of leukocytes in the peripheral blood. After activation, these cells modify their functional status to meet the needs at the site of action or according to the agent causing injury. They receive signals from their surroundings and “plan” the course of the response in both temporal and spatial contexts. PMNs dispose of intracellular signaling pathways that allow them to perform a wide range of functions associated with the development of inflammatory processes. In addition to these cells, some protein complexes, known as inflammasomes, also have a special role in the development and maintenance of inflammation. These complexes participate in the proteolytic activation of key pro-inflammatory cytokines, such as IL-1β and IL-18. In recent years, there has been significant progress in the understanding of the structure and molecular mechanisms behind the activation of inflammasomes and their participation in the pathogenesis of numerous diseases. The available reports focus primarily on macrophages and dendritic cells. According to the literature, the activation of inflammasomes in neutrophils and the associated death type—pyroptosis—is regulated in a different manner than in other cells. The present work is a review of the latest reports concerning the course of inflammasome activation and inflammatory cytokine secretion in response to pathogens in neutrophils, as well as the role of these mechanisms in the pathogenesis of selected diseases. Full article
(This article belongs to the Special Issue The Role and Characterization of Neutrophils in Human Diseases)
Show Figures

Figure 1

17 pages, 933 KiB  
Review
The Role of Neutrophils in Spondyloarthritis: A Journey across the Spectrum of Disease Manifestations
by Lavinia Agra Coletto, Chiara Rizzo, Giuliana Guggino, Roberto Caporali, Stefano Alivernini and Maria Antonietta D’Agostino
Int. J. Mol. Sci. 2023, 24(4), 4108; https://doi.org/10.3390/ijms24044108 - 18 Feb 2023
Cited by 4 | Viewed by 2507
Abstract
Spondyloarthritis (SpA) contemplates the inflammatory involvement of the musculoskeletal system, gut, skin, and eyes, delineating heterogeneous diseases with a common pathogenetic background. In the framework of innate and adaptive immune disruption in SpA, neutrophils are arising, across different clinical domains, as pivotal cells [...] Read more.
Spondyloarthritis (SpA) contemplates the inflammatory involvement of the musculoskeletal system, gut, skin, and eyes, delineating heterogeneous diseases with a common pathogenetic background. In the framework of innate and adaptive immune disruption in SpA, neutrophils are arising, across different clinical domains, as pivotal cells crucial in orchestrating the pro-inflammatory response, both at systemic and tissue levels. It has been suggested they act as key players along multiple stages of disease trajectory fueling type 3 immunity, with a significant impact in the initiation and amplification of inflammation as well as in structural damage occurrence, typical of long-standing disease. The aim of our review is to focus on neutrophils’ role within the spectrum of SpA, dissecting their functions and abnormalities in each of the relevant disease domains to understand their rising appeal as potential biomarkers and therapeutic targets. Full article
(This article belongs to the Special Issue The Role and Characterization of Neutrophils in Human Diseases)
Show Figures

Figure 1

42 pages, 4706 KiB  
Review
From Co-Infections to Autoimmune Disease via Hyperactivated Innate Immunity: COVID-19 Autoimmune Coagulopathies, Autoimmune Myocarditis and Multisystem Inflammatory Syndrome in Children
by Robert Root-Bernstein
Int. J. Mol. Sci. 2023, 24(3), 3001; https://doi.org/10.3390/ijms24033001 - 03 Feb 2023
Cited by 12 | Viewed by 2935
Abstract
Neutrophilia and the production of neutrophil extracellular traps (NETs) are two of many measures of increased inflammation in severe COVID-19 that also accompany its autoimmune complications, including coagulopathies, myocarditis and multisystem inflammatory syndrome in children (MIS-C). This paper integrates currently disparate measures of [...] Read more.
Neutrophilia and the production of neutrophil extracellular traps (NETs) are two of many measures of increased inflammation in severe COVID-19 that also accompany its autoimmune complications, including coagulopathies, myocarditis and multisystem inflammatory syndrome in children (MIS-C). This paper integrates currently disparate measures of innate hyperactivation in severe COVID-19 and its autoimmune complications, and relates these to SARS-CoV-2 activation of innate immunity. Aggregated data include activation of Toll-like receptors (TLRs), nucleotide-binding oligomerization domain (NOD) receptors, NOD leucine-rich repeat and pyrin-domain-containing receptors (NLRPs), retinoic acid-inducible gene I (RIG-I) and melanoma-differentiation-associated gene 5 (MDA-5). SARS-CoV-2 mainly activates the virus-associated innate receptors TLR3, TLR7, TLR8, NLRP3, RIG-1 and MDA-5. Severe COVID-19, however, is characterized by additional activation of TLR1, TLR2, TLR4, TLR5, TLR6, NOD1 and NOD2, which are primarily responsive to bacterial antigens. The innate activation patterns in autoimmune coagulopathies, myocarditis and Kawasaki disease, or MIS-C, mimic those of severe COVID-19 rather than SARS-CoV-2 alone suggesting that autoimmunity follows combined SARS-CoV-2-bacterial infections. Viral and bacterial receptors are known to synergize to produce the increased inflammation required to support autoimmune disease pathology. Additional studies demonstrate that anti-bacterial antibodies are also required to account for known autoantigen targets in COVID-19 autoimmune complications. Full article
(This article belongs to the Special Issue The Role and Characterization of Neutrophils in Human Diseases)
Show Figures

Figure 1

Other

Jump to: Research, Review

11 pages, 1661 KiB  
Perspective
Can Neutrophils Prevent Nosocomial Pneumonia after Serious Injury?
by Kristína Macáková, Elzbieta Kaczmarek and Kiyoshi Itagaki
Int. J. Mol. Sci. 2023, 24(8), 7627; https://doi.org/10.3390/ijms24087627 - 21 Apr 2023
Cited by 1 | Viewed by 1240
Abstract
Nosocomial pneumonia is a leading cause of critical illness and mortality among seriously injured trauma patients. However, the link between injury and the development of nosocomial pneumonia is still not well recognized. Our work strongly suggests that mitochondrial damage-associated molecular patterns (mtDAMPs), especially [...] Read more.
Nosocomial pneumonia is a leading cause of critical illness and mortality among seriously injured trauma patients. However, the link between injury and the development of nosocomial pneumonia is still not well recognized. Our work strongly suggests that mitochondrial damage-associated molecular patterns (mtDAMPs), especially mitochondrial formyl peptides (mtFPs) released by tissue injury, play a significant role in developing nosocomial pneumonia after a serious injury. Polymorphonuclear leukocytes (neutrophils, PMN) migrate toward the injury site by detecting mtFPs through formyl peptide receptor 1 (FPR1) to fight/contain bacterial infection and clean up debris. Activation of FPR1 by mtFPs enables PMN to reach the injury site; however, at the same time it leads to homo- and heterologous desensitization/internalization of chemokine receptors. Thus, PMN are not responsive to secondary infections, including those from bacteria-infected lungs. This may enable a progression of bacterial growth in the lungs and nosocomial pneumonia. We propose that the intratracheal application of exogenously isolated PMN may prevent pneumonia coupled with a serious injury. Full article
(This article belongs to the Special Issue The Role and Characterization of Neutrophils in Human Diseases)
Show Figures

Figure 1

Back to TopTop